Google Übersetzer
Arvinas, Inc.
About
Arvinas, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 18 2026
Arvinas Announces Positive Phase 1 Data for ARV-102 Showing Greater Than 50% LRRK2 Degradation in the CSF of Patients with Parkinson’s Disease Treated for 28 Days
Mar 11 2026
Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
Feb 24 2026
Arvinas Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Feb 17 2026
Arvinas to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Feb 12 2026
Arvinas Announces Appointment of Randy Teel, Ph.D., as President, Chief Executive Officer, and Director
Recent Videos
18 March 26. Biotech Stock News. Daily Recap2 #English #Shorts $XBI #trading #biotechnews #dailynews
Mar 18, 2026
18 Marzo 26. Noticias acciones biotecnológicas. Resumen diario. #Español #Shorts #diario $XBI #bio
Mar 18, 2026
FRESH MOMENTUM : ARVN STOCK ANALYSIS | ARVINAS STOCK
Dec 21, 2025
$ARVN Arvinas Inc - 60 Second Analysis - November 18, 2025 #ARVN #ARVINAS #STOCKMARKET #STOCKS
Nov 18, 2025